Leader in mRNA Technology
Ludwig – The Genomics Language Company is blazing a new trail in healthcare utilizing the body’s own language, mRNA, to measure and monitor critical biomarkers of chronic inflammation. Our cutting edge science will lead to the developmnet of personalized therapeutics targeting illnesses such as cancer, diabetes, COPD and heart disease.
Download Investor PresentationMission Statement
Ludwig – The Genomics Language Company™
Ludwig Enterprises, a biotech and healthcare holding company, is a global leader in mRNA genomics and machine learning AI technology. Our mission is to identify, monitor and create solutions to prevent chronic inflammation, the causative agent of illnesses which are responsible for 50% of deaths worldwide.
Precision Genomics
Ludwig – The Genomics Language Company is blazing a new trail in healthcare utilizing the body’s own language, mRNA, to measure and monitor critical biomarkers of chronic inflammation. Our cutting edge science will lead to the developmnet of personalized therapeutics targeting illnesses such as cancer, diabetes, COPD and heart disease.
NuGenea™
Ludwig – The Genomics Language Company is blazing a new trail in healthcare utilizing the body’s own language, mRNA, to measure and monitor critical biomarkers of chronic inflammation. Our cutting edge science will lead to the developmnet of personalized therapeutics targeting illnesses such as cancer, diabetes, COPD and heart disease.